A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 160
Summary
- Conditions
- Locally Advanced Renal Cell Carcinoma
- Locally Advanced Urothelial Cancer
- Metastatic Clear Cell Renal Cell Carcinoma
- Metastatic Melanoma
- Metastatic Non Small Cell Lung Cancer
- Metastatic Urothelial Cancer
- Unresectable Melanoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03679767
- Collaborators
- Not Provided
- Investigators
- Study Director: Mark Cornfeld, MD Incyte Corporation
Get Well Soon